Fate Therapeutics Funding & Investors
San Diego, CA
Fate Therapeutics, Inc. provides biotechnology services. The Company researches and develops therapies to repair and regenerate body tissues with the help of stem cells. Fate Therapeutics conducts business in the United States.
fatetherapeutics.comTotal Amount Raised: $1,240,928,256
Fate Therapeutics Funding Rounds
Post Ipo Equity
$100,000,000
Post Ipo Equity Investors
OrbiMed AdvisorsAdage Capital ManagementSuvretta Capital ManagementBoxer CapitalDeep Track CapitalPost Ipo Equity
$100,000,000
Post Ipo Equity Investors
OrbiMed AdvisorsAdage Capital ManagementSuvretta Capital ManagementBoxer CapitalDeep Track CapitalPost Ipo Equity
$100,000,000
Post Ipo Equity Investors
OrbiMed AdvisorsAdage Capital ManagementSuvretta Capital ManagementBoxer CapitalDeep Track CapitalPost Ipo Equity
$432,000,000
Post Ipo Equity
$432,000,000
Post Ipo Equity
$432,000,000
Post Ipo Equity
$201,300,000
Post Ipo Equity
$201,300,000
Post Ipo Equity
$173,000,000
Post Ipo Equity
$172,500,000
Grant
$4,000,000
Grant Investors
California Institute for Regenerative MedicinePost Ipo Equity
$42,900,000
Post Ipo Equity
$56,749,988
Post Ipo Equity
$10,290,000
Post Ipo Equity
$32,000,000
Post Ipo Equity
$8,000,000
Post Ipo Debt
$20,000,000
Post Ipo Debt Investors
Silicon Valley Bank (SVB)IPO
Unknown
Series Unknown
$9,200,000
Series B
$35,988,360
Series B Investors
Astellas Venture ManagementOVP Venture PartnersPolaris PartnersVenrockArch Venture PartnersDebt Financing
$1,000,000
Series B
$30,000,000
Series B Investors
OVP Venture PartnersAstellas Venture ManagementGenzymeArch Venture PartnersPolaris PartnersVenrockSeries A
$12,000,000
Series A Investors
Polaris PartnersArch Venture PartnersVenrockOVP Venture Partners